BRITTNEY HARRIS: Open Payments
NPI 1225511959 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$238 in 12 payments from 10 companies in 2025. Trend: 2023 $227 · 2024 $440 · 2025 $238
Food & beverage: $238
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $48 |
| Novo Nordisk Inc | 2 | $46 |
| ABBVIE INC. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Amgen Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| Exact Sciences Corporation | 1 | $15 |
| Stryker Corporation | 1 | $14 |
Products named: Ozempic, JARDIANCE, VRAYLAR, MOUNJARO, TRELEGY ELLIPTA, GEMTESA, AIRSUPRA, OTEZLA.
Industry payments across GA — which companies pay providers there.
